𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma

✍ Scribed by Dr. Alexander A. Green; F. Ann Hayes; H. Omar Hustu

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
693 KB
Volume
48
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide/doxorubicin vs. Cisplat
Cyclophosphamide/doxorubicin vs. Cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A pediatric oncology group randomized phase II study
✍ McWilliams, Nancy B. ;Hayes, F. Ann ;Green, A. A. ;Smith, E. Ide ;Nitschke, Rupr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract This prospective study was designed to estimate the response rates and to compare two drug pairs, cyclophosphamide/doxorubicin (Cy/A) and cisplatin/teniposide (P1/VM) in previously untreated patients with disseminated neuroblastoma >12 months of age at diagnosis. Estimated complete clin

Relation between the duration of remissi
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen
✍ Mary Ann Weiser; Maria E. Cabanillas; Marina Konopleva; Deborah A. Thomas; Sherr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Abstract ## BACKGROUND Hyperglycemia, which is not uncommon during the treatment of acute lymphocytic leukemia (ALL), has been shown to be an independent predictor of adverse outcomes among hospitalized patients with undiagnosed diabetes; it also may have the potential to affect leukemic cell p